ArrowMark Colorado Holdings LLC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 70 filers reported holding DYNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,426,447
-20.4%
382,4160.0%0.04%
-10.6%
Q2 2023$4,302,180
+35.7%
382,416
+39.0%
0.05%
+30.6%
Q1 2023$3,169,889
-0.6%
275,1640.0%0.04%
-5.3%
Q4 2022$3,189,151
-8.8%
275,1640.0%0.04%
-11.6%
Q3 2022$3,495,000
+201.8%
275,164
+63.3%
0.04%
+230.8%
Q2 2022$1,158,000
-28.7%
168,5000.0%0.01%
-7.1%
Q1 2022$1,624,000
-18.9%
168,5000.0%0.01%
-12.5%
Q4 2021$2,003,000
-26.8%
168,5000.0%0.02%
-23.8%
Q3 2021$2,736,000
-22.8%
168,5000.0%0.02%
-22.2%
Q2 2021$3,545,000
+128.3%
168,500
+68.5%
0.03%
+125.0%
Q1 2021$1,553,000
-26.0%
100,0000.0%0.01%
-25.0%
Q4 2020$2,100,000
-48.0%
100,000
-50.0%
0.02%
-57.9%
Q3 2020$4,038,000200,0000.04%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,960,046$35,195,00013.16%
MPM ASSET MANAGEMENT LLC 4,951,303$58,871,00012.72%
Atlas Venture Life Science Advisors, LLC 8,934,902$106,236,0009.76%
Logos Global Management LP 3,234,392$38,457,0003.97%
GREAT POINT PARTNERS LLC 845,000$10,047,0002.23%
Deep Track Capital, LP 2,292,250$27,255,0001.92%
Octagon Capital Advisors LP 583,649$6,940,0001.35%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 476,000$5,641,0001.26%
COMMODORE CAPITAL LP 305,125$3,628,0000.84%
RA Capital Management 2,805,045$33,352,0000.59%
View complete list of DYNE THERAPEUTICS INC shareholders